Avg closing price
Price range

6 Stanley Druckenmiller Alnylam Pharmaceuticals Trades

Stanley Druckenmiller's position in Alnylam Pharmaceuticals is currently worth $19.6 Million. That's 1.02% of their equity portfolio (23rd largest holding). The first Alnylam Pharmaceuticals trade was made in Q4 2019. Since then Stanley Druckenmiller bought shares three more times and sold shares on two occasions. The stake costed the investor $16.9 Million, netting the investor a gain of 16% so far.

Avg closing price
Price range
New holding (+88.9 Thousand shares) Q3 2022
Avg closing price $190.40
Price range $138.54 - $233.85
Sold -63.9 Thousand shares Q2 2022
Avg closing price $141.87
Price range $120.42 - $169.29
New holding (+63.9 Thousand shares) Q1 2022
Avg closing price $152.35
Price range $127.18 - $173.91
Sold -368 Thousand shares Q4 2020
Avg closing price $133.53
Price range $122.97 - $147.00
Increased shares by 217.1% (+252 Thousand shares) Q1 2020
Avg closing price $115.43
Price range $93.12 - $133.99
New holding (+116 Thousand shares) Q4 2019
Avg closing price $99.70
Price range $74.51 - $124.23

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!